SCHEMBL1833744

SCHEMBL1833744

CCCCCCCCC(C)OC(=O)O

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.59
CNR1 P21554 1/20 0.57
CNR2 P34972 1/20 0.57
ALDH1A1 P00352 1/20 0.55
GPR84 Q9NQS5 7/20 0.50
ACE2 Q9BYF1 1/20 0.50
FFAR1 O14842 1/20 0.50
MAPT P10636 1/20 0.48
LCK P06239 1/20 0.48
PPARD Q03181 1/20 0.48
ZDHHC20 Q5W0Z9 1/20 0.48
ZDHHC2 Q9UIJ5 1/20 0.48
LMNA P02545 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1835355 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL1840168 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL1839719 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL1840086 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL1837153 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL1837219 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL1836768 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL1833842 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL654708 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84
SCHEMBL1837800 1.00 FAAH (0.59) FAAHCNR1CNR2ALDH1A1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122055369-A Bridged tricyclic carbamoyl pyridone compounds and uses thereof 吉利德科学公司 2026-05-15 CN disclosed
CN-116891465-A N-substituted quinolinone compounds, preparation method and application thereof 苏州旺山旺水生物医药有限公司 2023-10-17 CN disclosed
CN-108463481-B Method for producing polycarbonate 国际壳牌研究有限公司 2021-04-09 CN disclosed
CN-108473672-B Process for preparing melt polycarbonate 国际壳牌研究有限公司 2020-12-08 CN disclosed
US-10654973-B2 Method for producing polycarbonate SHELL OIL COMPANY (US) 2020-05-19 US disclosed
US-10640609-B2 Method for preparing a melt polycarbonate SHELL OIL COMPANY (US) 2020-05-05 US disclosed
EP-3394146-B1 METHOD FOR PREPARING A MELT POLYCARBONATE SHELL INT RESEARCH (NL) 2019-10-30 EP disclosed
EP-3394149-B1 METHOD FOR PRODUCING POLYCARBONATE SHELL INT RESEARCH (NL) 2019-10-30 EP disclosed
US-20190010281-A1 METHOD FOR PRODUCING POLYCARBONATE OLIGOMERS SHELL OIL COMPANY 2019-01-10 US disclosed
US-20180371164-A1 METHOD FOR PRODUCING POLYCARBONATE SHELL OIL COMPANY (US) 2018-12-27 US disclosed
US-9249090-B2 N-substituted carbamic acid ester production method and isocyanate production method using the N-substituted carbamic acid ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-02-02 US disclosed
US-9145357-B2 N-substituted carbamic acid ester production method, isocyanate production method using such N-substituted carbamic acid ester, and composition for transfer and storage of N-substituted carbamic acid ester comprising N-substituted carbamic acid ester and aromatic hydroxy compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-09-29 US disclosed
US-20150038742-A1 N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-02-05 US disclosed
US-8884047-B2 N-substituted carbamic acid ester production method and isocyanate production method using the N-substituted carbamic acid ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-11-11 US disclosed
US-20140194650-A1 N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, and Composition for Transfer and Storage of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-07-10 US disclosed
US-8658819-B2 N-substituted carbamic acid ester production method, isocyanate production method using such N-substituted carbamic acid ester, and composition for transfer and storage of N-substituted carbamic acid ester comprising N-substituted carbamic acid ester and aromatic hydroxy compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-02-25 US disclosed
US-20110160476-A1 N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-06-30 US disclosed
US-20110133121-A1 N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-06-09 US disclosed
EP-2322504-A1 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER Asahi Kasei Chemicals Corporation (JP) 2011-05-18 EP disclosed
US-3931041-A LIQUID CRYSTAL COMPOSITIONS XEROX CORPORATION (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110133121-A1 N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound CPS1, ALKBH3, RCC1 FAAH 200/4885CNR1 400/4885CNR2 210/4885
US-20140194650-A1 N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, and Composition for Transfer and Storage of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound CPS1, ALKBH3, RCC1 FAAH 200/4885CNR1 400/4885CNR2 210/4885
US-10640609-B2 Method for preparing a melt polycarbonate PKD1, HSD17B7, DHCR7 FAAH 4453/4885CNR1 3211/4885CNR2 3141/4885
US-20110160476-A1 N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester ALKBH3, CPS1, APEH FAAH 130/4885CNR1 538/4885CNR2 427/4885
US-20150038742-A1 N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester ALKBH3, CPS1, APEH FAAH 130/4885CNR1 538/4885CNR2 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.